Dahlqvist G, Ciccarelli O, Van Vlierberghe H, Berrevoet F, Vanwolleghem T, Ysebaert D, Gustot T, Lucidi V, Delwaide J, Detry O, Delbouille M H, Sokal E, Nevens F, Pirenne J
UCL Liver Transplant Program; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
UZ Gent Liver Transplant Program, Universitair Ziekenhuis, Gent, Belgium.
Acta Gastroenterol Belg. 2020 Apr-Jun;83(2):340-343.
Since January 2020, the Novel Coronavirus Disease 2019 (COVID-19) pandemic has dramatically impacted the world. In March 2020, the COVID-19 epidemic reached Belgium creating uncertainty towards all aspects of life. There has been an impressive capacity and solidarity of all healthcare professionals to acutely reconvert facilities to treat these patients. In the context of liver transplantation (LTx), concerns are raised about organ donation shortage and safety, the ethics of using limited healthcare resources for LTx, selection criteria for LTx during the epidemic and the risk of de novo COVID-19 infection on the waiting list and after LTx. BeLIAC makes several recommendations to try to mitigate the deleterious effect that this epidemic has/will have on donation and LTx, taking into account the available resources, and trying to maximize patients and healthcare professionals' safety.
自2020年1月以来,2019新型冠状病毒病(COVID-19)大流行对全球产生了巨大影响。2020年3月,COVID-19疫情蔓延至比利时,给生活的方方面面带来了不确定性。所有医护人员展现出了令人钦佩的能力和团结精神,迅速改造设施以治疗这些患者。在肝移植(LTx)方面,人们对器官捐赠短缺和安全性、将有限的医疗资源用于肝移植的伦理问题、疫情期间肝移植的选择标准以及等待名单上和肝移植后新发COVID-19感染的风险感到担忧。比利时肝脏移植协会(BeLIAC)提出了几项建议,试图减轻这场疫情对捐赠和肝移植已经/将会产生的有害影响,同时考虑到可用资源,并努力最大限度地保障患者和医护人员的安全。